EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
about
Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2.AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma.p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlationsRANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor CellsSilencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.EGFR inhibitor enhances cisplatin sensitivity of human glioma cells.The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies.Epidermal Growth Factor Receptor Protein: A Biological Marker for Oral Precancer and CancerEstablishment of a Tongue Squamous Cell Carcinoma Cell Line from Indian Gutka Chewer
P2860
Q33754437-FC26F062-ED6E-411A-A046-7E387C671D79Q33844244-A683EB69-3778-447E-8580-270248315695Q35167498-F5AE6FA1-B71C-4BBA-A248-73F27CFC36CEQ35551953-361973F8-20EA-436D-8E55-53690930990BQ35767493-DDCB585B-387A-402E-B178-0F1FE9E1BB85Q36289932-1CFBF64B-23E9-44AB-ABCF-F31BF924C190Q36362955-2789CCAF-409D-4815-993E-5946CD14AA1AQ38751317-AF6B22C3-15CE-4691-BBC4-8BC2E17785D2Q39375139-D5EDE69C-9109-46B3-B818-C26EF27C5B07Q39427603-849EF8BD-C2D8-4313-90E3-AB85D942D858Q45065769-9BA4FC30-F014-4D2E-A436-3EFDDC77D835Q48151951-40A75195-64CA-4ABA-ACBE-3623B427D477Q59048655-3A7C1E37-4EA9-4049-AF0C-5BA573322A8EQ59049319-9BFBFC4C-E1C5-49AE-9397-D5A226BC290B
P2860
EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
@en
type
label
EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
@en
prefLabel
EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
@en
P2093
P2860
P1476
EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
@en
P2093
Itaru Tojyo
Ken Nakatani
Kenji Negoro
Norifumi Kiga
Shigeyuki Fujita
Takashi Matsumoto
Takeshi Wada
Yukihiro Hiraishi
P2860
P2888
P356
10.1007/S12253-008-9020-5
P577
2008-03-07T00:00:00Z